520 related articles for article (PubMed ID: 19166443)
21. Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia.
Farnier M; Chen E; Johnson-Levonas AO; McCrary Sisk C; Mitchel YB
Vasc Health Risk Manag; 2014; 10():279-90. PubMed ID: 24855368
[TBL] [Abstract][Full Text] [Related]
22. Extended-release niacin with laropiprant : a review on efficacy, clinical effectiveness and safety.
Yadav R; France M; Younis N; Hama S; Ammori BJ; Kwok S; Soran H
Expert Opin Pharmacother; 2012 Jun; 13(9):1345-62. PubMed ID: 22607011
[TBL] [Abstract][Full Text] [Related]
23. Safety and tolerability of extended-release niacin-laropiprant: Pooled analyses for 11,310 patients in 12 controlled clinical trials.
McKenney J; Bays H; Gleim G; Mitchel Y; Kuznetsova O; Sapre A; Sirah W; Maccubbin D
J Clin Lipidol; 2015; 9(3):313-25. PubMed ID: 26073389
[TBL] [Abstract][Full Text] [Related]
24. Flushing profile of extended-release niacin/laropiprant at initiation of therapy in Asian lipid clinic patients.
Kush D; Hu DY; Ye P; Kim HS; Chen E; Sirah W; McCrary Sisk C; Paolini JF; Maccubbin D
Cardiology; 2009; 114(3):192-8. PubMed ID: 19602880
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
[TBL] [Abstract][Full Text] [Related]
26. Safety of extended-release niacin/laropiprant in patients with dyslipidemia.
McKenney J; Bays H; Koren M; Ballantyne CM; Paolini JF; Mitchel Y; Betteridge A; Kuznetsova O; Sapre A; Sisk CM; Maccubbin D
J Clin Lipidol; 2010; 4(2):105-112.e1. PubMed ID: 21122637
[TBL] [Abstract][Full Text] [Related]
27. Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.
Bays H; Rhyne J; Abby S; Lai YL; Jones M
Curr Med Res Opin; 2006 Nov; 22(11):2191-200. PubMed ID: 17076980
[TBL] [Abstract][Full Text] [Related]
28. Extended-release niacin/laropiprant for lipid management: observational study in clinical practice.
Steinhagen-Thiessen E; Dänschel W; Buffleben C; Smolka W; Pittrow D; Hildemann SK
Int J Clin Pract; 2013 Jun; 67(6):527-35. PubMed ID: 23437867
[TBL] [Abstract][Full Text] [Related]
29. Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.
Bays HE; Brinton EA; Triscari J; Chen E; Maccubbin D; MacLean AA; Gibson KL; Ruck RA; Johnson-Levonas AO; O'Neill EA; Mitchel YB
Vasc Health Risk Manag; 2015; 11():165-72. PubMed ID: 25750540
[TBL] [Abstract][Full Text] [Related]
30. Extended-Release Niacin/Laropiprant Improves Overall Efficacy of Postprandial Reverse Cholesterol Transport.
El Khoury P; Waldmann E; Huby T; Gall J; Couvert P; Lacorte JM; Chapman J; Frisdal E; Lesnik P; Parhofer KG; Le Goff W; Guerin M
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):285-94. PubMed ID: 26681758
[TBL] [Abstract][Full Text] [Related]
31. Laropiprant plus niacin for dyslipidemia and prevention of cardiovascular disease.
Olsson AG
Expert Opin Pharmacother; 2010 Jul; 11(10):1715-26. PubMed ID: 20518616
[TBL] [Abstract][Full Text] [Related]
32. The resurgence of niacin: from nicotinic acid to niaspan/laropiprant.
Markel A
Isr Med Assoc J; 2011 Jun; 13(6):368-74. PubMed ID: 21809737
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and tolerability of a new extended-release formulation of nicotinic acid in Korean adults with mixed dyslipidemia: an 8-week, multicenter, prospective, randomized, double-blind, and placebo-controlled trial.
Kim SH; Kim MK; Lee HY; Kang HJ; Kim YJ; Park BJ; Kim HS
Clin Ther; 2011 Oct; 33(10):1357-64. PubMed ID: 21955937
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surface graph analysis.
Insull W; McGovern ME; Schrott H; Thompson P; Crouse JR; Zieve F; Corbelli J
Arch Intern Med; 2004 May; 164(10):1121-7. PubMed ID: 15159270
[TBL] [Abstract][Full Text] [Related]
35. Fixed-dose combination of extended-release niacin plus simvastatin for lipid disorders.
Vo AN; Kashyap ML
Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1303-10. PubMed ID: 19018682
[TBL] [Abstract][Full Text] [Related]
36. HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment.
HPS2-THRIVE Collaborative Group
Eur Heart J; 2013 May; 34(17):1279-91. PubMed ID: 23444397
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT
Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany.
Michailov GV; Davies GM; Krobot KJ
Eur J Health Econ; 2012 Jun; 13(3):365-74. PubMed ID: 21465286
[TBL] [Abstract][Full Text] [Related]
39. Adherence and persistence with single-dosage form extended-release niacin/lovastatin compared with statins alone or in combination with extended-release niacin.
LaFleur J; Thompson CJ; Joish VN; Charland SL; Oderda GM; Brixner DI
Ann Pharmacother; 2006; 40(7-8):1274-9. PubMed ID: 16849622
[TBL] [Abstract][Full Text] [Related]
40. Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes.
Brinton EA; Triscari J; Brudi P; Chen E; Johnson-Levonas AO; Sisk CM; Ruck RA; MacLean AA; Maccubbin D; Mitchel YB
Lipids Health Dis; 2016 Jul; 15(1):116. PubMed ID: 27405296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
